After this afternoon's -5.4% drop to $313.2 per share, Amgen might just keep moving past its target price of $329.14. With an average analyst rating of buy, and target prices from $200.0 to $381.0, the stock's next move is anyone's guess.
Amgen's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.6%. The stock's short ratio is 4.33. The company's insiders own 0.25% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 81.1%. In conclusion, we believe there is mixed market sentiment regarding Amgen.
Institutions Invested in Amgen
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 10% | 51,873,366 | $16,246,738,864 |
| 2024-06-30 | Blackrock Inc. | 9% | 46,042,729 | $14,420,583,284 |
| 2024-06-30 | State Street Corporation | 5% | 28,971,481 | $9,073,868,202 |
| 2024-06-30 | Primecap Management Company | 3% | 14,447,127 | $4,524,840,352 |
| 2024-06-30 | Morgan Stanley | 3% | 14,362,478 | $4,498,328,284 |
| 2024-06-30 | Geode Capital Management, LLC | 2% | 12,019,038 | $3,764,362,848 |
| 2024-06-30 | Charles Schwab Investment Management, Inc. | 2% | 10,280,753 | $3,219,931,965 |
| 2024-06-30 | Capital International Investors | 2% | 8,378,960 | $2,624,290,374 |
| 2024-06-30 | Wells Fargo & Company | 1% | 7,677,589 | $2,404,620,968 |
| 2024-06-30 | Bank of America Corporation | 1% | 6,036,762 | $1,890,713,932 |
